期刊文献+

MDM2与P_(16)在大肠癌中的表达及临床意义 被引量:3

Expression of MDM2 and P_(16) Gene in Colorectal Carcinoma
下载PDF
导出
摘要 目的探讨鼠双微基因2(MDM2)和多肿瘤抑制基因(P16)在大肠癌中的表达及临床意义。方法采用免疫组织化学链霉菌抗生物素蛋白—过氧化物酶(S-P)法,对67例大肠癌、30例癌旁组织、20例腺瘤组织,20例正常黏膜的MDM2和P16基因蛋白进行检测。结果MDM2在大肠癌组织中的阳性表达率为71.7%(48/67),明显高于结肠腺瘤组织、癌旁组织及正常黏膜,差异有显著性意义(P<0.05)。P16在大肠癌组织中的阳性表达率为38.8%(26/67),与结肠腺瘤组织的75%、癌旁组织的83.3%及正常黏膜组织的90%比较,差异均有显著性意义(P<0.05)。大肠癌组织中,MDM2在不同分化程度中表达差异无显著性意义(P>0.05)。P16在不同分化程度中表达差异有显著性意义(P<0.05),MDM2和P16在不同Dukes分期中有无淋巴转移之间表达,差异有显著性(P<0.05)。MDM2与P16基因蛋白,在不同年龄组、不同性别组中,表达差异无显著性(P>0.05)。在大肠癌中,MDM2蛋白与P16蛋白表达无明显相关性(P>0.05)。结论MDM2和P16的异常表达,与大肠癌的发生发展有关。联合检测MDM2和P16,对大肠癌的临床诊断、治疗和判断预后,有实际意义。 Objective To study expression of murine double minute gene 2(MDM2) and multiple tumor suppressor(P16) gene in colorectal cancers and its clinical significance.Methods The expression of MDM2 and P16 in 67 specimens of colorectal carcinoma,30 specimens of lateral tissue of carcinoma,20 specimens of colonic adenoma,and 20 specimens of normal colonic tissue was detected by S-P immunohistochemistry.Results In the tissues of colorectal carcinoma,the positive expression rate of MDM2 was 71.7%(48/67).The positive expression rates of MDM2 in the tissues of colorectal carcinoma was much higher than that in lateral tissue of carcinoma,colonic adenoma and the normal colonic tissue.there was significant different(P〈0.05).In the tissue of colorectal carcinoma,the positive expression rates of P16 was 38.8%(26/67),the positive expression rate of P16 in the tissues of colorectal carcinoma was much lower than in colonic adenoma which rate was 75%,in carcinoma which rate was 83.3%,in the normal colonic tissue whi h rate was 90%.there has significant different(P〈0.05).The positive expression rate of MDM2 in variantly differentiated colorectal carcinoma had no significant different(P〉0.05).The positive expression rate of P16 in variantly differentiated colorectal carcinoma had significant difference(P〈0.05).There were significant differences among colonic adenoma in different Dukes staging group,associated with lymphatic metastasis and without lymphatic metastasis(P〈0.05).There were insignificant difference among colonic adenoma in different age group,different gender group(P〉0.05).In the tissues of colorectal carcinoma,the positive expression of MDM2 and P16 had no obvious correlation(P〉0.05).Conclusion The variation of MDM2 and P16 expression in colorectal carcinoma contribute to the occurrence and development of the carcinoma.United detection of MDM2 and P16 could be an important index to treatment,diagnose and prognosis for colorectal carcinoma.
出处 《黑龙江医学》 2010年第2期81-84,共4页 Heilongjiang Medical Journal
关键词 大肠癌 鼠双微基因2 多肿瘤抑制基因 免疫组化 Colorectal Carcinoma MDM2 P16 Immunohistochemistry
  • 相关文献

参考文献15

  • 1Oliner J D,Kinzler K W,Mehzer P S,et al.Amplification of a gene encoding a p53-associated protein in human sarcomas[J].Nature,1992,358:80-3.
  • 2Fakharzaden S S,Trusko S P,George D L.Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line[J].EMBO J,1991,10(6):1 565-9.
  • 3Mc Queen C,Montgomery E,Dufour B,et al.Giant hypopharyngeal atypical lipomatous tumor[J].Adv Anat Pathol,2010,17(1):38-41.
  • 4Zhang M F,Zhang Z Y,Fu J,et al.Correlation between expression of p53,p21/WAFl,and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma[J].J Transl Med,2009,7(1):110.
  • 5Schmidt M K,Tommiska J,Broeks A,et al.Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309,and p53 expression on survival of breast cancer patients[J].Breast Cancer Res,2009,11(6):89.
  • 6黄照权,朱立健,周媛,庞恩桥,李春英,王晓冰,李华,黄柳明.MDM_2基因产物在大肠癌中的表达及其临床意义[J].右江民族医学院学报,2003,25(1):11-13. 被引量:2
  • 7熊首先,朱尤庆,何军.MDM2和p53在大肠癌组织中的表达及其意义[J].长江大学学报(自科版)(下旬),2007,4(1):11-13. 被引量:6
  • 8Abdel-Fattah G,Yoffe B,Krishnan B,Khaoustov V,Itani K.MDM2/p53 protein expression in the development of colorectal adenocarcinoma[J].J Gastrointest Surg,2000,4(1):109-114.
  • 9Liu W,He L,Ramirez J,Ratain M J.Interactions between MDM2 and TP53 Genetic Alterations,and Their Impact on Response to MDM2 Inhibitors andOther Chemotherapeutic Drugs in Cancer Cells[J].Clin Cancer Res,2009,15(24):7 602-7.
  • 10靳西凤,冉志华.RNA干扰技术与结肠癌[J].世界华人消化杂志,2006,14(20):2003-2008. 被引量:4

二级参考文献17

共引文献12

同被引文献27

  • 1李喜霞,郎旭宇,乔从进,崔慧林,郭睿.原癌基因pokemon mRNA及其蛋白在非小细胞肺癌中的表达和意义[J].中国组织化学与细胞化学杂志,2009,18(1):89-93. 被引量:5
  • 2肖凤,王伴青,温永顺.胃癌及其癌前病变组织中p16及p53蛋白的表达[J].第四军医大学学报,2005,26(3):286-287. 被引量:8
  • 3Kamb A,Gruis NA,Weaver-Feldhaus J,et al.A cell cycle regulator potentially involved in genesis of many tumor types Science,1994,264 (5157):436-440.
  • 4Pessler F, Pendergrast P S, Hernandez N. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts [ J ]. Mol CellBiol, 1997,17 (7) :3786-3798.
  • 5Morrison D J, Pendergrast P S, Stavropoulos P, et al. FBI-1, a factor that binds to the HIV-! inducer of short transcripts(IST) ,is a POZ domain protain [ J]. Nucleic Acid Res, 1999,5 (27) : 1251-1262.
  • 6Lee D K, Suh D, Edenberg H J, et al. POZ domain transcription factor, FBI-1 ,represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with CAA binding activity of SPL[J]. J Biol Chert,2002,277(30) :26761-26768.
  • 7Meada T, Hobbs R M, Merghoub T, et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression [ J ]. Nature ,2005,433 (7023) :278-285.
  • 8杨廷桐 方卓宁 李磊 等.大鼠肺鳞癌模型的建立.新乡医学院学报,1999,:315-317.
  • 9Kim R,Tanabe K,Uchida Y,et al. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy [ J ]. Cancer Chemother Pharmacol,2002,50 (5) :343-352.
  • 10Collins T, StoneJ R, WilliamsA J. All in the family : the BTB/POZ, KRAB,and SCAN domains [ J ]. Mol Cell Biol, 2001,21 ( 11 ) : 3609-3615.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部